1. Home
  2. DNLI vs ASH Comparison

DNLI vs ASH Comparison

Compare DNLI & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • ASH
  • Stock Information
  • Founded
  • DNLI 2013
  • ASH 1924
  • Country
  • DNLI United States
  • ASH United States
  • Employees
  • DNLI N/A
  • ASH N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • ASH Specialty Chemicals
  • Sector
  • DNLI Health Care
  • ASH Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • ASH Nasdaq
  • Market Cap
  • DNLI 4.5B
  • ASH 4.1B
  • IPO Year
  • DNLI 2017
  • ASH N/A
  • Fundamental
  • Price
  • DNLI $25.05
  • ASH $76.74
  • Analyst Decision
  • DNLI Strong Buy
  • ASH Strong Buy
  • Analyst Count
  • DNLI 11
  • ASH 8
  • Target Price
  • DNLI $38.90
  • ASH $102.86
  • AVG Volume (30 Days)
  • DNLI 788.0K
  • ASH 452.3K
  • Earning Date
  • DNLI 11-06-2024
  • ASH 11-06-2024
  • Dividend Yield
  • DNLI N/A
  • ASH 2.10%
  • EPS Growth
  • DNLI N/A
  • ASH 1.05
  • EPS
  • DNLI N/A
  • ASH 3.35
  • Revenue
  • DNLI N/A
  • ASH $2,113,000,000.00
  • Revenue This Year
  • DNLI N/A
  • ASH $1.09
  • Revenue Next Year
  • DNLI $283.75
  • ASH $4.54
  • P/E Ratio
  • DNLI N/A
  • ASH $19.48
  • Revenue Growth
  • DNLI 204.74
  • ASH N/A
  • 52 Week Low
  • DNLI $14.56
  • ASH $76.33
  • 52 Week High
  • DNLI $33.33
  • ASH $102.50
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 37.93
  • ASH 32.79
  • Support Level
  • DNLI $26.17
  • ASH $77.00
  • Resistance Level
  • DNLI $33.33
  • ASH $88.89
  • Average True Range (ATR)
  • DNLI 1.64
  • ASH 1.86
  • MACD
  • DNLI -0.13
  • ASH -0.77
  • Stochastic Oscillator
  • DNLI 0.66
  • ASH 7.23

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About ASH Ashland Inc.

Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.

Share on Social Networks: